Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Want to earn money from home free? Discover practical ideas to generate income without any financial commitment.
17,986 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Nvidia's CEO argues the AI data-center expansion is only beginning, with trillions more in infrastructure needed. Mar...
Binance filed a defamation lawsuit against The Wall Street Journal in New York, challenging a February report on Iran...
JPMorgan warns that retail investors showing signs of fatigue could temper stock demand as Iran-related tensions inte...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Retirees are quietly shifting toward bond ETFs, seeking steady income and downside protection. Three broad funds are ...
Investors often ask where will XRP's price be by 2030. This piece breaks down the key drivers, real-world adoption, a...
XRP breaks past $1.50 and overtakes BNB in market cap as open interest on Binance surges. The move suggests traders a...
Geopolitical strains in the Gulf collide with political turbulence in Washington, delivering a fresh round of market ...
Fraudsters used Nigel Farage cameo videos to push unregulated crypto tokens, sparking rapid price spikes and steep de...
Bitcoin is showing resilience as oil prices retreat, pointing to a possible shift in risk sentiment. This morning min...
If you want real estate exposure in a single fund, you’ll face choices that go beyond simple popularity. This guide c...